☰

Rachel Y. Ames - Publications

Affiliations: 
University of Texas at Austin, Austin, Texas, U.S.A. 
Tree Info Similar researchers PubMed Report error

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Leong WI, Ames RY, Haverkamp JM, Torres L, Kline J, Bans A, Rocha L, Gallotta M, Guiducci C, Coffman RL, Janatpour MJ. Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses. Oncotarget. 10: 7220-7237. PMID 31921384 DOI: 10.18632/Oncotarget.27322  0.502
2017 Ames RY, Ting LM, Gendlina I, Kim K, Macian F. The transcription factor NFAT1 participates in the induction of CD4(+) T cell functional exhaustion during Plasmodium yoelii infection. Infection and Immunity. PMID 28630062 DOI: 10.1128/Iai.00364-17  0.679
2009 McDermott U, Ames RY, Iafrate AJ, Maheswaran S, Stubbs H, Greninger P, McCutcheon K, Milano R, Tam A, Lee DY, Lucien L, Brannigan BW, Ulkus LE, Ma XJ, Erlander MG, et al. Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors. Cancer Research. 69: 3937-46. PMID 19366796 DOI: 10.1158/0008-5472.Can-08-4327  0.477
Show low-probability matches.